医疗保险是否应为前列腺癌早期检测的前列腺特异性抗原检测提供报销？第二部分：早期检测策略。 - Suppr | 超能文献

Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: Early detection strategies.

作者信息

Coley C M, Barry M J, Fleming C, Wasson J H, Fahs M C, Oesterling J E

机构信息

Medical Practices Evaluation Center, Massachusetts General Hospital, Boston 02114, USA.

出版信息

Urology. 1995 Aug;46(2):125-41. doi: 10.1016/s0090-4295(99)80181-2.

DOI:10.1016/s0090-4295(99)80181-2

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: Early detection strategies.医疗保险是否应为前列腺癌早期检测的前列腺特异性抗原检测提供报销？第二部分：早期检测策略。

Urology. 1995 Aug;46(2):125-41. doi: 10.1016/s0090-4295(99)80181-2.

2

Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate.医疗保险是否应为前列腺特异性抗原检测提供报销以用于早期发现前列腺癌？第一部分：构建辩论框架。

Urology. 1995 Jul;46(1):2-13. doi: 10.1016/s0090-4295(99)80151-4.

3

Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program.医疗保险是否应为前列腺癌早期检测的前列腺特异性抗原检测提供报销？第四部分：评估早期检测项目的风险和益处。

Urology. 1995 Oct;46(4):445-61. doi: 10.1016/S0090-4295(99)80255-6.

4

Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part III: Management strategies and outcomes.医疗保险是否应为前列腺癌早期检测的前列腺特异性抗原检测提供报销？第三部分：管理策略与结果。

Urology. 1995 Sep;46(3):277-89. doi: 10.1016/S0090-4295(99)80208-8.

5

[The prostate-specific antigen in the early recognition of prostate carcinoma].

Dtsch Med Wochenschr. 1996 Nov 29;121(48):1508-14. doi: 10.1055/s-2008-1043176.

6

Prostate specific antigen density of the transition zone for early detection of prostate cancer.用于早期检测前列腺癌的移行区前列腺特异性抗原密度

J Urol. 1998 Aug;160(2):411-8; discussion 418-9.

7

Screening for prostate cancer.前列腺癌筛查

Int Urol Nephrol. 2001;33(2):249-57. doi: 10.1023/a:1015290429403.

8

Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians.前列腺癌的早期检测。第一部分：检测的先验概率和有效性。美国医师学会。

Ann Intern Med. 1997 Mar 1;126(5):394-406. doi: 10.7326/0003-4819-126-5-199703010-00010.

9

Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen.

J Urol. 1990 Jun;143(6):1146-52; discussion 1152-4. doi: 10.1016/s0022-5347(17)40211-4.

10

[Urological diagnosis of prostate carcinoma].

Radiologe. 2003 Jun;43(6):432-40. doi: 10.1007/s00117-003-0913-8.

引用本文的文献

1

Usefulness of Total PSA Value in Prostate Diseases Diagnosis.总前列腺特异抗原值在前列腺疾病诊断中的应用价值

Acta Inform Med. 2016 Jun;24(3):156-61. doi: 10.5455/aim.2016.24.156-161. Epub 2016 Jun 4.

2

The efficiency of a sedative or analgesic supplement to periprostatic nerve blockage for pain control during transrectal ultrasound-guided prostate biopsy - a prospective, randomized, controlled, double blind study.经直肠超声引导前列腺活检中前列腺周围神经阻滞加镇静或镇痛辅助剂用于控制疼痛的效果 - 一项前瞻性、随机、对照、双盲研究。

Arch Med Sci. 2010 Oct;6(5):787-92. doi: 10.5114/aoms.2010.17096. Epub 2010 Oct 26.